These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38070160)

  • 21. Spontaneous remission of marginal zone B cell lymphoma in a patient with seropositive rheumatoid arthritis after discontinuation of infliximab-methotrexate treatment.
    Thonhofer R; Gaugg M; Kriessmayr M; Neumann HJ; Erlacher L
    Ann Rheum Dis; 2005 Jul; 64(7):1098-9. PubMed ID: 15958773
    [No Abstract]   [Full Text] [Related]  

  • 22. The facts about methotrexate in rheumatoid arthritis.
    Bannwarth B; Vernhes JP; Schaeverbeke T; Dehais J
    Rev Rhum Engl Ed; 1995; 62(7-8):471-3. PubMed ID: 8574608
    [No Abstract]   [Full Text] [Related]  

  • 23. Methotrexate pneumonitis in a patient with Crohn's disease, during the COVID pandemic: An unusual clinical case and review of the literature.
    de Los Mozos Ruano A; Casas Deza D; Calvo Galindo R; Solana Hidalgo MP; Aguirre Portu N; Aranda Alonso Á; Meriño Ibarra EE; García López S
    Gastroenterol Hepatol; 2021 Apr; 44(4):302-303. PubMed ID: 33051049
    [No Abstract]   [Full Text] [Related]  

  • 24. Pneumonitis induced by methotrexate in a patient with seronegative rheumatoid arthritis.
    Fernández Matilla M; Fernández-Llanio Comella N; Castellano Cuesta JA
    Reumatol Clin; 2015; 11(3):190-1. PubMed ID: 25631247
    [No Abstract]   [Full Text] [Related]  

  • 25. Methotrexate pneumonitis in a patient with rheumatoid arthritis.
    Clearkin R; Corris PA; Thomas SH
    Postgrad Med J; 1997 Sep; 73(863):603-4. PubMed ID: 9373613
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficacy and safety of methotrexate in combination with other non-biologic disease-modifying antirheumatic drugs (DMARDs) in treatment of rheumatoid arthritis.
    Castrejón I; Gibson KA; Pincus T
    Bull Hosp Jt Dis (2013); 2013; 71 Suppl 1():S20-8. PubMed ID: 24219037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comment: severe pancytopenia associated with methotrexate therapy for rheumatoid arthritis.
    Mofredj A; Baraka D; Charoud A
    Ann Pharmacother; 2002; 36(7-8):1295. PubMed ID: 12086573
    [No Abstract]   [Full Text] [Related]  

  • 28. Methotrexate-induced lung injury in patients with rheumatoid arthritis occurs with peripheral blood lymphocyte count decrease.
    Inokuma S; Kono H; Kohno Y; Hiramatsu K; Ito K; Shiratori K; Yamazaki J; Nakayama H; Shoda H; Tanaka Y
    Ann Rheum Dis; 2006 Aug; 65(8):1113-4. PubMed ID: 16837494
    [No Abstract]   [Full Text] [Related]  

  • 29. [Cutaneous and haematological adverse events after methotrexate therapy].
    Rossau AK; Pedersen PT; Bygum A
    Ugeskr Laeger; 2015 Jan; 177(4):V65620. PubMed ID: 25613207
    [No Abstract]   [Full Text] [Related]  

  • 30. Eosinophilia as a side-effect of methotrexate in patients with chronic arthritis.
    Savolainen HA; Leirisalo-Repo M
    Clin Rheumatol; 2001; 20(6):432-4. PubMed ID: 11771529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early rheumatoid arthritis treated with tocilizumab, methotrexate, or their combination (U-Act-Early): a multicentre, randomised, double-blind, double-dummy, strategy trial.
    Bijlsma JWJ; Welsing PMJ; Woodworth TG; Middelink LM; Pethö-Schramm A; Bernasconi C; Borm MEA; Wortel CH; Ter Borg EJ; Jahangier ZN; van der Laan WH; Bruyn GAW; Baudoin P; Wijngaarden S; Vos PAJM; Bos R; Starmans MJF; Griep EN; Griep-Wentink JRM; Allaart CF; Heurkens AHM; Teitsma XM; Tekstra J; Marijnissen ACA; Lafeber FPJ; Jacobs JWG
    Lancet; 2016 Jul; 388(10042):343-355. PubMed ID: 27287832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination DMARD therapy with hydroxychloroquine, sulfasalazine, and methotrexate.
    O'Dell JR
    Clin Exp Rheumatol; 1999; 17(6 Suppl 18):S53-8. PubMed ID: 10589358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cryptococcal meningoencephalitis in a patient with rheumatoid arthritis treated with methotrexate and prednisone.
    Trillos RF; Fernández-Ávila DG; Díaz MC; Gutiérrez JM
    Reumatol Clin; 2014; 10(5):346-7. PubMed ID: 24746915
    [No Abstract]   [Full Text] [Related]  

  • 34. Reversible leukoencephalopathy after oral methotrexate.
    Koppen H; Wessels JA; Ewals JA; Treurniet FE
    J Rheumatol; 2012 Sep; 39(9):1906-7. PubMed ID: 22942312
    [No Abstract]   [Full Text] [Related]  

  • 35. Effectiveness of biologics in Australian patients with rheumatoid arthritis: a large observational study: REAL.
    Nicholls D; Barrett R; Button P; Truman M; Bird P; Roberts L; Tymms K; Littlejohn G; Griffiths H
    Intern Med J; 2018 Oct; 48(10):1185-1192. PubMed ID: 29968400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is methotrexate oncogenic in patients with rheumatoid arthritis?
    Kremer JM
    Semin Arthritis Rheum; 1997 Jun; 26(6):785-7. PubMed ID: 9213376
    [No Abstract]   [Full Text] [Related]  

  • 37. Pre-treatment X-rays for rheumatoid arthritis treated with methotrexate.
    Richards AJ
    Br J Rheumatol; 1997 Nov; 36(11):1234-5. PubMed ID: 9402875
    [No Abstract]   [Full Text] [Related]  

  • 38. More on pericardial tamponade during methotrexate therapy.
    Marchesoni A; Battafarano N; Beltrametti P
    J Rheumatol; 1996 Dec; 23(12):2182-4. PubMed ID: 8970065
    [No Abstract]   [Full Text] [Related]  

  • 39. Therapies for active rheumatoid arthritis after methotrexate failure.
    O'Dell JR; Mikuls TR; Taylor TH; Ahluwalia V; Brophy M; Warren SR; Lew RA; Cannella AC; Kunkel G; Phibbs CS; Anis AH; Leatherman S; Keystone E;
    N Engl J Med; 2013 Jul; 369(4):307-18. PubMed ID: 23755969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Methotrexate: mainstay of rheumatoid arthritis treatment].
    Jacobs JW; Bijlsma JW
    Ned Tijdschr Geneeskd; 2009; 153():A879. PubMed ID: 19785862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.